Join
Live feed
·
INSIDERFilingvia Quantisnow
Serina Therapeutics Inc. logo

Director Venkatesan Jay bought $1,048 worth of shares (589 units at $1.78) and converted options into 224,152 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SER· Serina Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SER (Serina Therapeutics Inc.) and more on Quantisnow.